Supplementary Table S3 from Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group
Authors:
- Elliot StieglitzESElliot Stieglitz
- Alex G. LeeALAlex G. Lee
- Steven P. AngusSASteven P. Angus
- Christopher DavisCDChristopher Davis
- Donald A. BarkauskasDBDonald A. Barkauskas
- David HallDHDavid Hall
- Scott C. KoganSKScott C. Kogan
- Julia MeyerJMJulia Meyer
- Steven D. RhodesSRSteven D. Rhodes
- Sarah K. TasianSTSarah K. Tasian
- Xiaoling XueiXXXiaoling Xuei
- Kevin ShannonKSKevin Shannon
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)